APLS vs EIX · rev $781.4M vs P/E 7.3, rev $17.60B
Apellis Pharmaceuticals Inc (APLS) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported APLS revenue for 2024-12-31 was $781.4M. Net income was -$197.9M. Revenue was up 97.0% from 2023-12-31 to 2024-12-31. APLS currently screens at market cap $2.29B.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
APLS currently screens at market cap $2.29B. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the APLS and EIX stock pages for the full models.
Not investment advice.